Geode Capital Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.47M | Buy |
|
|||||
|
2025
Q1 | $3.74M | Buy |
|
|||||
|
2024
Q4 | $6.15M | Buy |
|
|||||
|
2024
Q3 | $6.32M | Buy |
|
|||||
|
2024
Q2 | $8.49M | Buy |
|
|||||
|
2024
Q1 | $9.05M | Buy |
|
|||||
|
2023
Q4 | $5.73M | Buy |
|
|||||
|
2023
Q3 | $5.01M | Buy |
|
|||||
|
2023
Q2 | $6.76M | Buy |
|
|||||
|
2023
Q1 | $2.11M | Buy |
|
|||||
|
2022
Q4 | $1.66M | Buy |
|
|||||
|
2022
Q3 | $1.6M | Buy |
|
|||||
|
2022
Q2 | $1.6M | Buy |
|
|||||
|
2022
Q1 | $2.01M | Sell |
|
|||||
|
2021
Q4 | $953K | Buy |
|
|||||
|
2021
Q3 | $732K | Buy |
|
|||||
|
2021
Q2 | $1.15M | Sell |
|
|||||
|
2021
Q1 | $2.19M | Buy |
|
|||||
|
2020
Q4 | $2.8M | Sell |
|
|||||
|
2020
Q3 | $4.23M | Sell |
|
|||||
|
2020
Q2 | $5.11M | Buy |
|
|||||
|
2020
Q1 | $3.63M | Buy |
|
|||||
|
2019
Q4 | $5.35M | Buy |
|
|||||
|
2019
Q3 | $6.55M | Buy |
|
|||||
|
2019
Q2 | $10.1M | Buy |
|
|||||
|
2019
Q1 | $6.06M | Buy |
|
|||||
|
2018
Q4 | $2.7M | Buy |
|
|||||
|
2018
Q3 | $4.42M | Buy |
|
|||||
|
2018
Q2 | $4.56M | Buy |
|
|||||
|
2018
Q1 | $3.52M | Buy |
|
|||||
|
2017
Q4 | $2.87M | Buy |
|
|||||
|
2017
Q3 | $2.91M | Buy |
|
|||||
|
2017
Q2 | $610K | Buy |
|
|||||
|
2017
Q1 | $827K | Buy |
|
|||||
|
2016
Q4 | $738K | Buy |
|
|||||
|
2016
Q3 | $665K | Buy |
|
|||||
|
2016
Q2 | $587K | Buy |
|
|||||
|
2016
Q1 | $458 | Buy |
|
|||||
|
2015
Q4 | $963K | Buy |
|